Parathyroid hormone modifies human periodontal ligament cell proliferation and survival in vitro

Journal of Periodontal Research

Volumn 41, Issue 6, 2006, Pages 519-526

  Lossdorfer S ^a   Gotz W ^a   Jager A ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Apoptosis; Human PDL cells; Proliferation; PTH

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; DNA FRAGMENT; NITRIC OXIDE; PARATHYROID HORMONE; PARATHYROID HORMONE (1 34); PARATHYROID HORMONE (1-34); PEPTIDE FRAGMENT;

ADOLESCENT; ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CATTLE; CELL PROLIFERATION; CELL SURVIVAL; CHILD; CYTOLOGY; DRUG EFFECT; HUMAN; METABOLISM; PERIODONTAL LIGAMENT; TIME;

ADOLESCENT; ANIMALS; APOPTOSIS; CATTLE; CELL PROLIFERATION; CELL SURVIVAL; CHILD; DNA FRAGMENTATION; HUMANS; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PERIODONTAL LIGAMENT; TIME FACTORS;

EID: 33750437214     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2006.00899.x     Document Type: Article

References (36)

1. Yang ZJ, Cheng V, Barnes S, Cavalho L, Sindrey D. Pulsatile parathyroid hormone (PTH) treatment increases bone formation in vitro in a fetal rat calvarial cell (FRCC) culture system. J Bone Miner Res 1997;12:S317.
2. Iida-Klein A, Zhou H, Lu S et al. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. J Bone Miner Res 2002;17:808-816.
3. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 1996;104:439-446.
4. Zerega B, Cermelli S, Bianco P, Cancedda R, Cancedda FD. Parathyroid hormone [PTH(1-34)] and parathyroid hormone-related protein [PTHrP(1-34)] promote reversion of hypertrophic chondrocytes to a prehypertrophic proliferating phenotype and prevent terminal differentiation of osteoblast-like cells. J Bone Miner Res 1999;14:1281-1289.
5. Turner PR, Mefford S, Christakos S, Nissenson RA. Apoptosis mediated by activation of the G protein-coupled receptor for parathyroid hormone (PTH)/ PTH-related protein (PTHrP). Mol Endocrinol 2000;14:241-254.
6. Chen H, Demiralp B, Schneider A et al. Parathyroid hormone and parathyroid hormone-related protein exert both pro-and anti-apoptotic effects in mesenchymal cells. J Biol Chem 2002;277:19374-19381.
7. Nohutcu RM, Somerman MJ, McCauley LK. Dexamethasone enhances the effects of parathyroid hormone on human periodontal ligament cells in vitro. Calcif Tissue Int 1995;56:571-577.
8. Ouyang H, McCauley L, Berry J, D'Errico J, Strayhorn C, Somerman M. Response of immortalized murine cementoblasts/periodontal ligament cells to parathyroid hormone and parathyroid hormone related protein in vitro. Arch Oral Biol 2000;45:293-303.
9. Lossdörfer S, Götz W, Jäger A. PTH(1-34) affects OPG production in human PDL cells in vitro. J Dent Res 2005;84:634-638.
10. Lossdörfer S, Stier S, Götz W, Jäger A. Maturation-state dependent response of human periodontal ligament cells to an intermittent parathyroid hormone exposure in vitro. J Periodont Res 2006;41:62-72.
11. Kuzin B, Roberts I, Peunova N, Enikolopov G. Nitric oxide regulates cell proliferation during Drosophila development. Cell 1996;87:639-649.
12. Dimmeler S, Zeiher AM. Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide 1997;1:275-281.
13. Kim YM, Bombeck CA, BillarTR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 1999;84:253-256.
14. Kerezoudis NP, Olgart L, Fried K. Localization of NADPH-diaphorase activity in the dental pulp, periodontium and alveolar bone of the rat. Histochemistry 1993;100:319-322.
15. Lohinai Z, Szekely AD, Benedek P, Csillag A. Nitric oxide synthase containing nerves in the cat and dog dental pulp and gingiva. Neurosci Lett 1997;227:91-94.
16. Kikuiri T, Hasegawa T, Yoshimura Y, Shirakawa T, Oguchi H. Cyclic tension force activates nitric oxide production in cultured human periodontal ligament cells. J Periodontol 2000;71:533-539.
17. Hayashi K, Igarashi K, Miyohi K, Shinoda H, Mitani H. Involvement of nitric oxide in orthodontic tooth movement in rats. Am J Orthod Dentofacial Orthop 2002;122:306-309.
18. Shirazi M, Nilforoushan D, Agashi H, Dehpour AR. The role of nitric oxide in orthodontic toth movement in rats. Angle Orthod 2002;72:211-215.
19. Mancini L, Moradi-Bidhendi N, Brandi ML, Becherini L, Martineti V, MacIntyre I. The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependent. Biochem Biophys Res Commun 2000;274:391-397.
20. Isogai Y, Akatsu T, Ishizuya T et al. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. J Bone Miner Res 1996;11:1384-1393.
21. Nakajima A, Shimoji N, Shiomi K et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 2002;17:2038-2047.
22. Stanislaus D, Yang X, Liang J et al. In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone, hPTH 1-34 fragment. Bone 2000;27:209-218.
23. Evan G, Littlewood T. A matter of life and cell death. Science 1998;281:1317-1321.
24. Sheikh M, Fornance A. Death and decoy receptors and p53-mediated apoptosis. Leukemia 2000;14:1509-1513.
25. Bellido T, Ali AA, Plotkin LI et al. Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts: a putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 2003;278:50259-50272.
26. Ma YL, Cain R, Halladay D et al. Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 2001;142:4047-4054.
27. McCauley LK, Koh AJ, Beecher CA, Cui Y, Rosol TJ, Franceschi RT. PTH/PTHrP receptor is temporally regulated during osteoblast differentiation and is associated with collagen synthesis. J Cell Biochem 1996;61:638-647.
28. Bos MP, van der Meer JM, Feyen JH, Herrmann-Erlee MP. Expression of the parathyroid hormone receptor and correlation with other osteoblastic parameters in fetal rat osteoblasts. Calcif Tissue Int 1996;58:95-100.
29. Kondo H, Ohyama T, Ohya K, Kasugai S. Temporal changes of mRNA expression of matrix proteins and parathyroid hormone and parathyroid hormone-related protein (PTH/PTHrP) receptor in bone development. J Bone Miner Res 1997;12:2089-2097.
30. Damoulis PD, Hauschka PV. Nitric oxide acts in conjunction with proinflammatory cytokines to promote cell death in osteoblasts. J Bone Miner Res 1997;12:412-422.
31. Mogi M, Kinpara K, Kondo A, Togari A. Involvement of nitric oxide and biopterin in proinflammatory cytokine-induced apoptotic cell death in mouse osteoblastic cell line MC3T3-E1. Biochem Pharmacol 1999;58:649-654.
32. O'Shaughnessy MC, Polak JM, Afzal F et al. Nitric oxide mediates 17β-estradiol-stimulated human and rodent osteoblast proliferation and differentiation. Biochem Biophys Res Commun 2000;277:604-610.
33. Ralston SH, Todd D, Helfrich M, Benjamin N, Grabowski PS. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 1994;135:330-336.
34. Klein-Nulend J, Helfrich MH, Sterck JG et al. Nitric oxide response to shear stress by human bone cell culture is endothelial nitric oxide synthase dependent. Biochem Biophys Res Commun 1998;250:108-114.
35. Armour KE, Ralston SH. Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. Endocrinology 1998;139:799-802.
36. Bakker AD, Joldersma M, Klein-Nulend J, Burger EH. Interactive effects of PTH and mechanical stress on nitric oxide and PGE2 production by primary mouse osteoblastic cells. Am J Physiol Endocrinol Metab 2003;285:E608-E613.